Cited by 169Metabolism, Diabetes, and CancerFOXO transcription factor regulationPancreatic function and diabetes

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo

Open access

Titchenell, Paul M., Chu, Qingwei, Monks, Bobby R., Birnbaum, Morris J.·2015·Nature Communications

Open this paper in CoChat — free account Open PDF

Abstract

Insulin signalling and nutrient levels coordinate the metabolic response to feeding in the liver. Insulin signals in hepatocytes to activate Akt, which inhibits Foxo1 suppressing hepatic glucose production (HGP) and allowing the transition to the postprandial state. Here we provide genetic evidence that insulin regulates HGP by both direct and indirect hepatic mechanisms. Liver-specific ablation of the IR (L-Insulin Receptor KO) induces glucose intolerance, insulin resistance and prevents the appropriate transcriptional response to feeding. Liver-specific deletion of Foxo1 (L-IRFoxo1DKO) rescues glucose tolerance and allows for normal suppression of HGP and gluconeogenic gene expression in response to insulin, despite lack of autonomous liver insulin signalling. These data indicate that in the absence of Foxo1, insulin signals via an intermediary extrahepatic tissue to regulate liver glucose production. Importantly, a hepatic mechanism distinct from the IR–Akt–Foxo1 axis exists to regulate glucose production. Insulin and the transcription factor FoxO1 are key regulators of hepatic glucose metabolism. Here, Titchenell et al. provide evidence for the existence of an insulin-dependent extrahepatic pathway that is fully capable of regulating hepatic glucose production in the absence of hepatic FoxO1.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/ncomms8078

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487
Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction.
Michael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296
A Muscle-Specific Insulin Receptor Knockout Exhibits Features of the Metabolic Syndrome of NIDDM without Altering Glucose Tolerance
Brüning, J. C., Michael, M. D., Winnay, J. N., Hayashi, T., Hörsch, D., Accili, D., Goodyear, L. J., & Kahn, C. R. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80155-0 · Cited by 1,173
The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism
Koo, S., Flechner, L., Qi, L., Zhang, X., Screaton, R. A., Jeffries, S., Hedrick, S. A., Xu, W., Boussouar, F., Brindle, P. K., et al. (2005) · Nature · doi:10.1038/nature03967 · Cited by 1,026
Spatial Control of the TSC Complex Integrates Insulin and Nutrient Regulation of mTORC1 at the Lysosome
Menon, S., Dibble, C. C., Talbott, G., Hoxhaj, G., Valvezan, A. J., Takahashi, H., Cantley, L. C., & Manning, B. D. (2014) · Cell · doi:10.1016/j.cell.2013.11.049 · Cited by 766
Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis
Li, S., Brown, M. S., & Goldstein, J. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914798107 · Cited by 733
Insulin Action in AgRP-Expressing Neurons Is Required for Suppression of Hepatic Glucose Production
Könner, A. C., Janoschek, R., Plum, L., Jordan, S. D., Rother, E., Ma, X., Xu, C., Enriori, P., Hampel, B., Barsh, G. S., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.004 · Cited by 695
Akt Stimulates Hepatic SREBP1c and Lipogenesis through Parallel mTORC1-Dependent and Independent Pathways
Yecies, J. L., Zhang, H., Menon, S., Liu, S., Yecies, D. W., Lipovsky, A. I., Görgün, C. Z., Kwiatkowski, D. J., Hotamışlıgil, G. S., Lee, C., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.002 · Cited by 685
Impaired Regulation of Hepatic Glucose Production in Mice Lacking the Forkhead Transcription Factor Foxo1 in Liver
Matsumoto, M., Pocai, A., Rossetti, L., DePinho, R. A., & Accili, D. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.08.006 · Cited by 624

Show all 43 references

Sorted by citations

Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
The PI3K/AKT Pathway in Obesity and Type 2 Diabetes
Huang, X., Liu, G., Guo, J., & Su, Z. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.27173 · Cited by 1,673
“Additionally, those mice still maintained the normal postprandial state, even in the absence of canonical liver insulin signalling [85, 87].”
BackgroundResult
The integrative biology of type 2 diabetes
Roden, M., & Shulman, G. I. (2019) · Nature · doi:10.1038/s41586-019-1797-8 · Cited by 1,167
Regulation of hepatic glucose metabolism in health and disease
Petersen, M. C., Vatner, D. F., & Shulman, G. I. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.80 · Cited by 1,159
NAFLD and diabetes mellitus
Tilg, H., Moschen, A. R., & Roden, M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.147 · Cited by 1,002
A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance
Jang, C., Oh, S. F., Wada, S., Rowe, G. C., Liu, L., Chan, M. C., Rhee, J., Hoshino, A., Kim, B., Ibrahim, A., et al. (2016) · Nature Medicine · doi:10.1038/nm.4057 · Cited by 604
Self-citation
Insulin regulation of gluconeogenesis
Hatting, M., Tavares, C. D. J., Sharabi, K., Rines, A. K., & Puigserver, P. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13435 · Cited by 625
Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate
Zhao, S., Jang, C., Liu, J., Uehara, K., Gilbert, M., Izzo, L., Zeng, X., Trefely, S., Fernandez, S., Carrer, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2101-7 · Cited by 553
Self-citation
Role of Insulin Resistance in MAFLD
Sakurai, Y., Kubota, N., Yamauchi, T., & Kadowaki, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084156 · Cited by 448
Unraveling the Regulation of Hepatic Metabolism by Insulin
Titchenell, P. M., Lazar, M. A., & Birnbaum, M. J. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.03.003 · Cited by 457
Self-citation
Fox transcription factors: from development to disease
Golson, M. L., & Kaestner, K. H. (2016) · Development · doi:10.1242/dev.112672 · Cited by 406
Insulin Receptor Isoforms in Physiology and Disease: An Updated View
Belfiore, A., Malaguarnera, R., Vella, V., Lawrence, M. C., Sciacca, L., Frasca, F., Morrione, A., & Vigneri, R. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00073 · Cited by 390
FoxO integration of insulin signaling with glucose and lipid metabolism
Lee, S., & Dong, H. H. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0002 · Cited by 365
Resolving the paradox of hepatic insulin resistance
Santoleri, D., & Titchenell, P. M. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.10.016 · Cited by 336
“These mice also fail to promote hepatic lipogenesis in response to a high carbohydrate meal.(16) Resolving what specific factors mediate insulin action on the liver to generate these paradoxical effects has become a major focus in obesity and T2DM studies and has provided many insights into the molecular mechanisms of…”
BackgroundSelf-citation
Hepatic Selective Insulin Resistance at the Intersection of Insulin Signaling and Metabolic Dysfunction-Associated Steatotic Liver Disease
Bo, T., Gao, L., Yao, Z., Shao, S., Wang, X., Proud, C. G., & Zhao, J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.04.006 · Cited by 293
Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production
Titchenell, P. M., Quinn, W. J., Lu, M., Chu, Q., Lu, W., Li, C., Chen, H., Monks, B. R., Chen, J., Rabinowitz, J. D., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.04.022 · Cited by 298
Self-citation
FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization
O-Sullivan, I., Zhang, W., Wasserman, D. H., Liew, C. W., Liu, J., Paik, J., DePinho, R. A., Stolz, D. B., Kahn, C. R., Schwartz, M. W., et al. (2015) · Nature Communications · doi:10.1038/ncomms8079 · Cited by 228
Metabolic drivers of non-alcoholic fatty liver disease
Bence, K. K., & Birnbaum, M. J. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101143 · Cited by 230
Self-citation
Hepatic NADH reductive stress underlies common variation in metabolic traits
Goodman, R. P., Markhard, A. L., Shah, H., Sharma, R., Skinner, O. S., Clish, C. B., Deik, A., Patgiri, A., Hsu, Y.-H. H., Masia, R., et al. (2020) · Nature · doi:10.1038/s41586-020-2337-2 · Cited by 211
Brain insulin signalling in metabolic homeostasis and disease
Scherer, T., Sakamoto, K., & Buettner, C. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00498-x · Cited by 205
New targets for NAFLD
Parlati, L., Régnier, M., Guillou, H., & Postic, C. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100346 · Cited by 201
Ins and outs of the TCA cycle: the central role of anaplerosis
Inigo, M., Deja, S., & Burgess, S. C. (2021) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-120420-025558 · Cited by 189
Inter‐organ communication: a gatekeeper for metabolic health
Castillo‐Armengol, J., Fajas, L., & Lopez‐Mejia, I. C. (2019) · The EMBO Reports · doi:10.15252/embr.201947903 · Cited by 178
Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism
Tang, Y., Wallace, M., Sánchez-Gurmaches, J., Hsiao, W., Li, H., Lee, P. L., Vernia, S., Metallo, C. M., & Guertin, D. A. (2016) · Nature Communications · doi:10.1038/ncomms11365 · Cited by 188
Imbalanced Insulin Actions in Obesity and Type 2 Diabetes: Key Mouse Models of Insulin Signaling Pathway
Kubota, T., Kubota, N., & Kadowaki, T. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.03.004 · Cited by 174
Ginsenoside Rg1 Inhibits Glucagon-Induced Hepatic Gluconeogenesis through Akt-FoxO1 Interaction
Liu, Q., Zhang, F.-G., Zhang, W., Pan, A., Yang, Y., Liu, J., Li, P., Liu, B., & Qi, L. (2017) · Theranostics · doi:10.7150/thno.18788 · Cited by 158
Central injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents
Scarlett, J. M., Rojas, J. M., Matsen, M. E., Kaiyala, K. J., Stefanovski, D., Bergman, R. N., Hồng, N. T., Dorfman, M. D., Lantier, L., Wasserman, D. H., et al. (2016) · Nature Medicine · doi:10.1038/nm.4101 · Cited by 150
Obesity: Pathophysiology, monosodium glutamate-induced model and anti-obesity medicinal plants
Hernández-Bautista, R., Mahmoud, A. M., Königsberg, M., & López‐Díazguerrero, N. E. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.108 · Cited by 158
Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis
Wang, J., Yang, W., Chen, Z., Chen, J., Meng, Y., Feng, B., Sun, L., Dou, L., Li, J., Cui, Q., et al. (2018) · Diabetes · doi:10.2337/db17-0799 · Cited by 138
Potential Nexus of Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Insulin Resistance Between Hepatic and Peripheral Tissues
Mu, W., Cheng, X., Liu, Y., Lv, Q., Gao-lin, L., Zhang, J.-G., & Li, X. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01566 · Cited by 127
The PI3K/Akt signaling axis and type 2 diabetes mellitus (T2DM): From mechanistic insights into possible therapeutic targets
Taheri, R., Mokhtari, Y., Yousefi, A., & Bashash, D. (2024) · Cell Biology International · doi:10.1002/cbin.12189 · Cited by 116
Inactivating hepatic follistatin alleviates hyperglycemia
Tao, R., Wang, C., Stöhr, O., Qiu, W., Hu, Y., Miao, J., Dong, X. C., Leng, S., Stefater, M., Stylopoulos, N., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0048-0 · Cited by 104
Intercellular Transmission of Hepatic ER Stress in Obesity Disrupts Systemic Metabolism
Tirosh, A., Tuncman, G., Calay, E. S., RATHAUS, M., Ron, I., Tirosh, A., Yalçın, A., Lee, Y. G., Livne, R., Ron, S., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.11.009 · Cited by 106
Muscle Directs Diurnal Energy Homeostasis through a Myokine-Dependent Hormone Module in Drosophila
Zhao, X. L., & Karpac, J. (2017) · Current Biology · doi:10.1016/j.cub.2017.06.004 · Cited by 93
Hypothalamic Control of Systemic Glucose Homeostasis: The Pancreas Connection
Pozo, M., & Claret, M. (2018) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2018.05.001 · Cited by 97
Hypothalamic Insulin Resistance in Obesity: Effects on Glucose Homeostasis
Chen, W., Balland, É., & Cowley, M. A. (2017) · Neuroendocrinology · doi:10.1159/000455865 · Cited by 101
mTORC1 stimulates phosphatidylcholine synthesis to promote triglyceride secretion
Quinn, W. J., Wan, M., Shewale, S. V., Gelfer, R., Rader, D. J., Birnbaum, M. J., & Titchenell, P. M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci96036 · Cited by 96
Self-citation
Hepatic Dysfunction Caused by Consumption of a High-Fat Diet
Soltis, A. R., Kennedy, N. J., Xin, X., Zhou, F., Ficarro, S. B., Yap, Y. S., Matthews, B. J., Lauffenburger, D. A., White, F. M., Marto, J. A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.059 · Cited by 100
Sphingolipid metabolism in non-alcoholic fatty liver diseases
Régnier, M., Polizzi, A., Guillou, H., & Loiseau, N. (2018) · Biochimie · doi:10.1016/j.biochi.2018.07.021 · Cited by 88
Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications
Truong, X. T., & Lee, D. H. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0644 · Cited by 84
“In mice, concomitant deletion of FoxO1 in an AKT-deficient liver is not sufficient to drive DNL but restores insulin sensitivity and glucose tolerance, suggesting there are other pathways downstream of AKT that contribute to DNL [12,32].”
Integrated Regulation of Hepatic Lipid and Glucose Metabolism by Adipose Triacylglycerol Lipase and FoxO Proteins
Zhang, W., Bu, S. Y., Mashek, M. T., O‐Sullivan, I., Sibai, Z., Khan, S. A., Ilkayeva, O., Newgard, C. B., Mashek, D. G., & Unterman, T. G. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.021 · Cited by 82
Physiological Suppression of Lipotoxic Liver Damage by Complementary Actions of HDAC3 and SCAP/SREBP
Papazyan, R., Sun, Z., Kim, Y. H., Titchenell, P. M., Hill, D. A., Lu, W., Damle, M., Wan, M., Zhang, Y., Briggs, E. R., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.012 · Cited by 80
Self-citation
Fu Brick Tea Manages HFD/STZ-Induced Type 2 Diabetes by Regulating the Gut Microbiota and Activating the IRS1/PI3K/Akt Signaling Pathway
Qi, B., Ren, D., Li, T., Niu, P., Zhang, X., Yang, X., & Xiao, J. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c02400 · Cited by 76
Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin
Acierno, C., Caturano, A., Pafundi, P. C., Nevola, R., Adinolfi, L. E., & Sasso, F. C. (2020) · Exploration of Medicine · doi:10.37349/emed.2020.00019 · Cited by 81
Metabolic Role of PTEN in Insulin Signaling and ResistancePreprint
Li, Y. Z., Cristofano, A. D., & Woo, M. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036137 · Cited by 76
Hepatic Glucagon Receptor Signaling Enhances Insulin-Stimulated Glucose Disposal in Rodents
Kim, T., Holleman, C. L., Nason, S. R., Arble, D. M., Ottaway, N., Chabenne, J. R., Loyd, C., Kim, J., Sandoval, D. A., Drucker, D. J., et al. (2018) · Diabetes · doi:10.2337/db18-0068 · Cited by 69
LRG1 is an adipokine that mediates obesity-induced hepatosteatosis and insulin resistance
He, S., Ryu, J., Liu, J., Luo, H., Lv, Y., Langlais, P. R., Wen, J., Dong, F., Sun, Z., Xia, W., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148545 · Cited by 71
Triglycerides in Nonalcoholic Fatty Liver Disease: Guilty Until Proven Innocent
Semova, I., & Biddinger, S. B. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.12.001 · Cited by 69
Insulin signaling and reduced glucocorticoid receptor activity attenuate postprandial gene expression in liver
Kalviša, A., Siersbæk, M. S., Præstholm, S. M., Christensen, L. J. L., Nielsen, R., Stöhr, O., Vettorazzi, S., Tuckermann, J. P., White, M. F., Mandrup, S., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2006249 · Cited by 63
The role of adipose tissue dysfunction in hepatic insulin resistance and T2D
Sancar, G., & Birkenfeld, A. L. (2024) · Journal of Endocrinology · doi:10.1530/joe-24-0115 · Cited by 69
FoxO1 antagonist suppresses autophagy and lipid droplet growth in adipocytes
Liu, L., Zheng, L., Zou, P., Brooke, J., Smith, C., Long, Y. C., Almeida, F. A., Liu, D., & Cheng, Z. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1192732 · Cited by 60
The adipocyte supersystem of insulin and cAMP signaling
Guilherme, A., Rowland, L. A., Wang, H., & Czech, M. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.07.009 · Cited by 59
Targeting insulin to the liver corrects defects in glucose metabolism caused by peripheral insulin delivery
Edgerton, D. S., Scott, M. F., Farmer, B., Williams, P. E., Madsen, P., Kjeldsen, T., Brand, C. L., Fledelius, C., Nishimura, E., & Cherrington, A. D. (2019) · JCI Insight · doi:10.1172/jci.insight.126974 · Cited by 61
Glucoregulatory Relevance of Small Intestinal Nutrient Sensing in Physiology, Bariatric Surgery, and Pharmacology
Duca, F. A., Bauer, P. V., Hamr, S. C., & Lam, T. K. T. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.003 · Cited by 62
A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway
Wu, F., Shao, Q., Xia, Q., Hu, M., Zhao, Y. Q., Wang, D., Fang, K., Xu, L., Zou, X., Chen, Z., et al. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153487 · Cited by 53
Hypothalamic growth hormone receptor (GHR) controls hepatic glucose production in nutrient-sensing leptin receptor (LepRb) expressing neurons
Cady, G., Landeryou, T., Garratt, M., Kopchick, J. J., Qi, N., García-Galiano, D., Elias, C. F., Myers, M. G., Miller, R. A., Sandoval, D. A., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.03.001 · Cited by 52
Liver and insulin resistance: New wine in old bottle!!!
Patel, B. M., & Goyal, R. K. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172657 · Cited by 51
Insulin Regulation of Hepatic Lipid Homeostasis
Uehara, K., Santoleri, D., Whitlock, A. E. G., & Titchenell, P. M. (2023) · Comprehensive Physiology · doi:10.1002/cphy.c220015 · Cited by 49
Self-citation
Pathophysiological Relationship between Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Therapeutic Approaches
Ferdous, S.-E., & Ferrell, J. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168731 · Cited by 56
The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver
Hörbelt, T., Knebel, B., Fahlbusch, P., Barbosa, D., de Wiza, D. H., de Velde, F. V., Nieuwenhove, Y. V., Lapauw, B., Thoresen, G. H., Al‐Hasani, H., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.07.008 · Cited by 47
Modeling and therapeutic targeting of inflammation-induced hepatic insulin resistance using human iPSC-derived hepatocytes and macrophages
Gröger, M., Matsuo, K., Arash, E. H., Pereira, A., Guillou, D. L., Pino, C., Telles-Silva, K. A., Maher, J. J., Hsiao, E. C., & Willenbring, H. (2023) · Nature Communications · doi:10.1038/s41467-023-39311-w · Cited by 47
MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1
Luo, A., Yan, H., Liang, J., Du, C., Zhao, X., Sun, L., & Chen, Y. (2017) · Gene · doi:10.1016/j.gene.2017.06.024 · Cited by 44
Astragaloside IV Inhibits Adipose Lipolysis and Reduces Hepatic Glucose Production via Akt Dependent PDE3B Expression in HFD-Fed Mice
Du, Q., Zhang, S., Li, A., Mohammad, I. S., Liu, B., & Li, Y. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00015 · Cited by 45
Regulation of Glucose Production in the Pathogenesis of Type 2 Diabetes
Sargsyan, A., & Herman, M. A. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1195-5 · Cited by 42
Niacin fine‐tunes energy homeostasis through canonical GPR109A signaling
Ye, L., Cao, Z., Lai, X., Wang, W., Guo, Z., Yan, L., Wang, Y., Shi, Y., & Zhou, N. (2018) · The FASEB Journal · doi:10.1096/fj.201801951r · Cited by 38
Hypoinsulinaemic, hypoketotic hypoglycaemia due to mosaic genetic activation of PI3-kinase
Leiter, S. M., Parker, V., Welters, A., Knox, R. G., Rocha, N., Clark, G. R., Payne, F., Lotta, L. A., Harris, J. R., Guerrero-Fernández, J., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0132 · Cited by 38
Hepatocyte ABCA1 Deletion Impairs Liver Insulin Signaling and Lipogenesis
Key, C.-C. C., Liu, M., Kurtz, C. L., Chung, S., Boudyguina, E. Y., Dinh, T. A., Bashore, A. C., Phelan, P. E., Freedman, B. I., Osborne, T. F., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.032 · Cited by 40
High‐fat diet in a mouse insulin‐resistant model induces widespread rewiring of the phosphotyrosine signaling network
Dittmann, A., Kennedy, N. J., Soltero, N. L., Morshed, N., Mana, M., Yilmaz, Ö. H., Davis, R. J., & White, F. M. (2019) · Molecular Systems Biology · doi:10.15252/msb.20198849 · Cited by 34
Haploinsufficiency of the Insulin Receptor in the Presence of a Splice-Site Mutation in Ppp2r2a Results in a Novel Digenic Mouse Model of Type 2 Diabetes
Goldsworthy, M., Bai, Y., Li, C.-M., Ge, H., Lamas, E., Hilton, H., Esapa, C. T., Baker, D., Baron, W., Juan, T., et al. (2016) · Diabetes · doi:10.2337/db15-1276 · Cited by 35
l -Cysteine supplementation increases insulin sensitivity mediated by upregulation of GSH and adiponectin in high glucose treated 3T3-L1 adipocytes
Elumalai, A., & Jain, S. K. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.07.016 · Cited by 31
Sirtuin function and metabolism: Role in pancreas, liver, and adipose tissue and their crosstalk impacting bone homeostasis
Avilkina, V., Chauveau, C., & Mhenni, O. G. (2021) · Bone · doi:10.1016/j.bone.2021.116232 · Cited by 33
Deconstructing the Role of PKC Epsilon in Glucose Homeostasis
Schmitz‐Peiffer, C. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.01.016 · Cited by 30
Dietary inositol improved glucose and lipid metabolism mediated by the Insulin-PI3K-Akt signaling pathway in Pacific white shrimp (Litopenaeus vannamei)
Lu, J., Tao, X., Li, M., Zhang, X., Zhou, Q., Luo, J., Zhu, T., Jiao, L., & Jin, M. (2023) · Aquaculture · doi:10.1016/j.aquaculture.2023.739910 · Cited by 29
FoxO1 Is Required for Most of the Metabolic and Hormonal Perturbations Produced by Hepatic Insulin Receptor Deletion in Male Mice
Ling, A. V., Gearing, M. E., Semova, I., Shin, D., Clements, R. L., Lai, Z. W., & Biddinger, S. B. (2017) · Endocrinology · doi:10.1210/en.2017-00870 · Cited by 30
TOX4, an insulin receptor-independent regulator of hepatic glucose production, is activated in diabetic liver
Wang, L., Yu, J., Zhou, Q., Wang, X., Mukhanova, M., Du, W. J., Sun, L., Pajvani, U. B., & Accili, D. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.11.013 · Cited by 28
Regulation of Hepatic Glucose Metabolism by FoxO Proteins, an Integrated Approach
Unterman, T. G. (2017) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2017.10.005 · Cited by 28
Loss of FOXO transcription factors in the liver mitigates stress-induced hyperglycemia
Whitlock, A. E. G., Sostre‐Colón, J., Gavin, M. J., Martin, N. D., Baur, J. A., Sims, C. A., & Titchenell, P. M. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101246 · Cited by 29
Self-citation
Hepatic AKT orchestrates adipose tissue thermogenesis via FGF21-dependent and -independent mechanisms
Sostre‐Colón, J., Uehara, K., Whitlock, A. E. G., Gavin, M. J., Ishibashi, J., Potthoff, M. J., Seale, P., & Titchenell, P. M. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109128 · Cited by 26
Self-citation
Insulin–Dendrimer Nanocomplex for Multi‐Day Glucose‐Responsive Therapy in Mice and Swine
Xian, S., Xiang, Y., Liu, D., Fan, B., Mitrová, K., Ollier, R. C., Su, B., Alloosh, M. A., Jiráček, J., Sturek, M. S., et al. (2023) · Advanced Materials · doi:10.1002/adma.202308965 · Cited by 26
Increased intracellular iron in mouse primary hepatocytes in vitro causes activation of the Akt pathway but decreases its response to insulin
Varghese, J., James, J., Vaulont, S., McKie, A. T., & Jacob, M. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.05.022 · Cited by 25
Enhancement of Adiponectin Ameliorates Nonalcoholic Fatty Liver Disease via Inhibition of FoxO1 in Type I Diabetic Rats
Xie, X., Yan, D., Li, H., Zhu, Q., Li, J., Fang, Y., Cheung, C. W., Irwin, M. G., Xia, Z., & Lian, Q. (2018) · Journal of Diabetes Research · doi:10.1155/2018/6254340 · Cited by 27
Crosstalk between bone and other organs
Yuan, W., & Song, C. (2022) · Medical Review · doi:10.1515/mr-2022-0018 · Cited by 27
Adipocyte JAK2 Regulates Hepatic Insulin Sensitivity Independently of Body Composition, Liver Lipid Content, and Hepatic Insulin Signaling
Corbit, K. C., Camporez, J. P., Edmunds, L. R., Tran, J. L., Vera, N. B., Erion, D. M., Deo, R. C., Perry, R. J., Shulman, G. I., Jurczak, M. J., et al. (2017) · Diabetes · doi:10.2337/db17-0524 · Cited by 20
Myeloid-specific deletion of Zfp36 protects against insulin resistance and fatty liver in diet-induced obese mice
Caracciolo, V., Young, J., Gonzales, D. M., Ni, Y., Flowers, S. J., Summer, R. S., Waldman, S. A., Kim, J. K., Jung, D. Y., Noh, H. L., et al. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00224.2017 · Cited by 20
Partial impairment of insulin receptor expression mimics fasting to prevent diet-induced fatty liver disease
Merry, T. L., Hedges, C. P., Masson, S. W. C., Laube, B., Pöhlmann, D., Wueest, S., Walsh, M. E., Arnold, M., Langhans, W., Konrad, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15623-z · Cited by 20
Hepatic IGF2/H19 Epigenetic Alteration Induced Glucose Intolerance in Gestational Diabetes Mellitus Offspring via FoxO1 Mediation
Jiang, Y., Zhu, H., Chen, Z., Yu, Y., Guo, X., Chen, Y., Yang, M., Chen, B.-W., Sagnelli, M., Xu, D. Q., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.844707 · Cited by 21
An integrative transcriptional logic model of hepatic insulin resistance
Kitamoto, T., Kuo, T., Okabe, A., Kaneda, A., & Accili, D. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102222118 · Cited by 20
Insulin Resistance in Type 2 Diabetes
Roden, M., Petersen, K. F., & Shulman, G. I. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch13 · Cited by 20
Modulation of Glucose Production by Central Insulin Requires IGF-1 Receptors in AgRP Neurons
Quipildor, G. F., Mao, K., Beltran, P. J., Barzilai, N., & Huffman, D. M. (2021) · Diabetes · doi:10.2337/db21-0028 · Cited by 19
IPMK modulates hepatic glucose production and insulin signaling
Jung, I., Anokye‐Danso, F., Jin, S., Ahima, R. S., & Kim, S. F. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30827 · Cited by 19
FoxO1: mute for a tuned metabolism?
Cheng, Z. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.06.006 · Cited by 19
Exploring histone deacetylases in type 2 diabetes mellitus: pathophysiological insights and therapeutic avenues
Kumar, K. K., Aburawi, E. H., Ljubisavljević, M., Leow, M. K., Xu, F., Ansari, S. A., & Emerald, B. S. (2024) · Clinical Epigenetics · doi:10.1186/s13148-024-01692-0 · Cited by 22
Regulation of Hepatic Metabolism, Recent Advances, and Future Perspectives
Sharabi, K., Tavares, C. D. J., & Puigserver, P. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1224-4 · Cited by 21
Whole grains-derived functional ingredients against hyperglycemia: targeting hepatic glucose metabolism
Wang, Y., Fan, M., Qian, H., Ying, H., Li, Y., & Wang, L. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2183382 · Cited by 20
Role of AMPD2 in impaired glucose tolerance induced by high fructose diet
Hudoyo, A. W., Hirase, T., Tandelilin, A., Honda, M., Shirai, M., Cheng, J., Morisaki, H., & Morisaki, T. (2017) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2017.07.006 · Cited by 18
MicroRNA-185 modulates CYP7A1 mediated cholesterol-bile acid metabolism through post-transcriptional and post-translational regulation of FoxO1
Zhang, J., Wang, X., Huajun, J., Yang, F., Du, Y., Wang, L., & Hong, B. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.03.007 · Cited by 17
Estradiol (E2) Improves Glucose-Stimulated Insulin Secretion and Stabilizes GDM Progression in a Prediabetic Mouse Model
Liebmann, M., Pfeifer, M. A., Grupe, K., & Scherneck, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126693 · Cited by 18
FOXO: a key target in regulating aging and age-related diseases
Wang, W., Zhu, H., Jiang, Q., Shi, Y., & Wang, X. (2026) · Biogerontology · doi:10.1007/s10522-025-10380-2 · Cited by 18
The complex interplay between oxinflammation, mitochondrial dysfunction and lipotoxicity: Focus on their role in the pathogenesis of skeletal muscle insulin resistance and modulation by dietary fatty acids
Passaro, A., Sanz, J. M., Naumovski, N., & Sergi, D. (2024) · Advances in Redox Research · doi:10.1016/j.arres.2024.100100 · Cited by 17
Linagliptin Ameliorates Hepatic Steatosis via Non-Canonical Mechanisms in Mice Treated with a Dual Inhibitor of Insulin Receptor and IGF-1 Receptor
Okuyama, T., Shirakawa, J., Tajima, K., Ino, Y., Vethe, H., Togashi, Y., Kyohara, M., Inoue, R., Miyashita, D., Li, J., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217815 · Cited by 14

Authors: Titchenell, P. M., Chu, Q., Monks, B. R., & Birnbaum, M. J.
Affiliations: University of Pennsylvania (US)
Corresponding author: Birnbaum, Morris J.
ORCID: Titchenell, Paul M.
Birnbaum, Morris J.
Venue: Nature Communications
Publisher: Springer Science and Business Media LLC
Published: 2015-05-12
Volume: 6
Issue: 1
Pages: 7078-7078
ISSN: 2041-1723 (ISSN-L)
DOI: 10.1038/ncomms8078
PMC: PMC4429930
OpenAlex: W240175869
Cited by: 169
References: 43
Citations by year: 2026: 7 · 2025: 13 · 2024: 11 · 2023: 14 · 2022: 18 · 2021: 15 · 2020: 15 · 2019: 11 · 2018: 19 · 2017: 24 · 2016: 14 · 2015: 8
FWCI: 9.41
Type: journal article
Language: en
Open access: gold
doi.org
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Communications (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK056886, F32DK101175)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Keywords: hepatic glucose production, FOXO1, insulin receptor, Akt, gluconeogenesis, impaired glucose tolerance, insulin resistance, liver-specific knockout, postprandial glucose metabolism, hepatic glucose metabolism
MeSH terms: Forkhead Box Protein O1, Animals, Gene Expression Regulation, Gluconeogenesis, Glucose, Glucose Tolerance Test, Insulin Resistance, Liver, Male, Receptor, Insulin, RNA, Messenger, Signal Transduction, Mice, Knockout, Mice, Forkhead Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks